Mylan Infringed Cephalon Painkiller Patents, Judge Says

Law360, New York (July 22, 2013, 6:50 PM EDT) -- A Delaware federal judge on Monday ruled that Mylan Pharmaceuticals Inc. infringed three patents for Cephalon Inc.'s cancer painkiller drug Fentora, saying the former company's proposed generic version of the drug includes components covered by the patents.

U.S. District Judge Sue Robinson said in a Monday order that Mylan infringed U.S. Patent Numbers 6,200,604; 6,974,590; and 8,119,158, through its attempts to market a generic version of Fentora. Judge Robinson also found that the 158 patent and another related patent, U.S. Patent Number 8,092,832, are valid.

The patents, which Cima Inc. owns and licenses exclusively to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.